Jagsonpal Pharmaceuticals (India) Buy Hold or Sell Recommendation

JAGSNPHARM   636.65  9.80  1.52%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Jagsonpal Pharmaceuticals Limited is 'Buy'. The recommendation algorithm takes into account all of Jagsonpal Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Jagsonpal Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Jagsonpal and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Execute Jagsonpal Pharmaceuticals Buy or Sell Advice

The Jagsonpal recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Jagsonpal Pharmaceuticals Limited. Macroaxis does not own or have any residual interests in Jagsonpal Pharmaceuticals Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Jagsonpal Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Jagsonpal PharmaceuticalsBuy Jagsonpal Pharmaceuticals
Buy

Market Performance

GoodDetails

Volatility

Very steadyDetails

Hype Condition

Under hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Jagsonpal Pharmaceuticals Limited has a Risk Adjusted Performance of 0.1527, Jensen Alpha of 0.7068, Total Risk Alpha of 0.5606, Sortino Ratio of 0.2298 and Treynor Ratio of 0.756
Macroaxis provides investment recommendation on Jagsonpal Pharmaceuticals to complement and cross-verify current analyst consensus on Jagsonpal Pharmaceuticals. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Jagsonpal Pharmaceuticals Limited is not overpriced, please check out all Jagsonpal Pharmaceuticals fundamentals, including its net income, and the relationship between the price to book and earnings per share .

Jagsonpal Pharmaceuticals Trading Alerts and Improvement Suggestions

Jagsonpal Pharmaceuticals appears to be risky and price may revert if volatility continues
About 76.0% of the company shares are held by company insiders
Latest headline from news.google.com: Jagsonpal Pharmas Stock Reaches 52-Week High, Outperforms Sector and Sensex - MarketsMojo

Jagsonpal Pharmaceuticals Returns Distribution Density

The distribution of Jagsonpal Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Jagsonpal Pharmaceuticals' future price movements. The chart of the probability distribution of Jagsonpal Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Jagsonpal Pharmaceuticals Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Jagsonpal Pharmaceuticals returns is essential to provide solid investment advice for Jagsonpal Pharmaceuticals.
Mean Return
0.75
Value At Risk
-5.25
Potential Upside
10.80
Standard Deviation
4.15
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Jagsonpal Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Jagsonpal Pharmaceuticals Cash Flow Accounts

201920202021202220232024 (projected)
Change To Inventory33.7M(4.0M)(176K)90.7M53.1M55.8M
Change In Cash(4.6M)191.3M(329.1M)(114.7M)17.1M17.9M
Free Cash Flow91.8M277.5M51.3M463.4M349.2M366.6M
Depreciation11.3M10.9M15.3M12.1M16.6M15.0M
Other Non Cash Items(35.5M)(63.3M)(61.2M)(2.4M)(78.1M)(74.2M)
Capital Expenditures20.7M4.7M4.7M3.2M2.5M2.4M
Net Income94.1M218.7M273.2M348.1M224.6M116.5M
End Period Cash Flow380.7M589.4M260.3M110.5M127.6M184.2M
Dividends Paid13.1M26.2M104.8M0.0131.0M137.5M
Net Borrowings(45.2M)8.8M(67.9M)(3.2M)(2.9M)(3.0M)
Change To Netincome(19.5M)(15.2M)16.1M88.8M102.2M107.3M

Jagsonpal Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Jagsonpal Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Jagsonpal Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Jagsonpal stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.71
β
Beta against Dow Jones0.98
σ
Overall volatility
4.27
Ir
Information ratio 0.17

Jagsonpal Pharmaceuticals Volatility Alert

Jagsonpal Pharmaceuticals Limited shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Jagsonpal Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Jagsonpal Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Jagsonpal Pharmaceuticals Fundamentals Vs Peers

Comparing Jagsonpal Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Jagsonpal Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Jagsonpal Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Jagsonpal Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Jagsonpal Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Jagsonpal Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Jagsonpal Pharmaceuticals to competition
FundamentalsJagsonpal PharmaceuticalsPeer Average
Return On Equity0.13-0.31
Return On Asset0.0605-0.14
Profit Margin0.11 %(1.27) %
Operating Margin0.19 %(5.51) %
Current Valuation16.46 B16.62 B
Shares Outstanding26.55 M571.82 M
Shares Owned By Insiders76.28 %10.09 %
Shares Owned By Institutions1.47 %39.21 %
Price To Book8.71 X9.51 X
Price To Sales7.45 X11.42 X
Revenue2.09 B9.43 B
Gross Profit1.43 B27.38 B
EBITDA323.46 M3.9 B
Net Income224.63 M570.98 M
Cash And Equivalents110.53 M2.7 B
Total Debt89.41 M5.32 B
Book Value Per Share74.42 X1.93 K
Cash Flow From Operations351.66 M971.22 M
Earnings Per Share8.99 X3.12 X
Number Of Employees1.02 K18.84 K
Beta1.06-0.15
Market Capitalization16.9 B19.03 B
Total Asset2.17 B29.47 B
Retained Earnings1.04 B9.33 B
Working Capital1.8 B1.48 B
Annual Yield0.01 %
Net Asset2.17 B

Jagsonpal Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Jagsonpal . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Jagsonpal Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Jagsonpal Pharmaceuticals Limited? Buying financial instruments such as Jagsonpal Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Jagsonpal Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Municipals ETFs Thematic Idea Now

Municipals ETFs
Municipals ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Municipals ETFs theme has 111 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Municipals ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Jagsonpal Stock

Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.